Anthony P Polednak1. 1. Connecticut Tumor Registry, Connecticut Department of Public Health, 410 Capitol Avenue, Hartford, CT 06134-0308, USA. anthony.polednak@ct.gov
Abstract
BACKGROUND: Reaching the American Cancer Society challenge goal for the nation to reduce cancer incidence by 25% by 2015 will be influenced in part by the epidemic of obesity. The purpose of this study was to estimate the impact of obesity on the number obesity-attributable incident cancers in the U.S. in 2007 and on trends on cancer incidence rates. METHODS: Using estimated relative risks (RRs) for obesity vs. normal weight/height from published meta-analyses and/or large cohort studies, and the prevalence of obese adults from the latest national surveys, attributable risk percent (ARP) and numbers of obesity-attributed incident cancers in 2007 were estimated. Using the ARPs, the impact of obesity trends on trends in incidence rates for certain obesity-related cancers was estimated for the calendar years (1976-1980 through 2001-2004) for which cancer rates and obesity prevalence rates were available. RESULTS: An estimated 33,966 new cancers (4% of all estimated cancers) in males and 50,535 (7% of all estimated cancers) in females diagnosed in 2007, or 6% of all cancers, may be potentially attributable to obesity. Without the impact of rising obesity rates, incidence rates might have declined (instead of remaining stable) from 1988-1994 to 2001-2004 for uterus, breast and certain other cancers. CONCLUSIONS: Obesity may contribute to about 6% of U.S. incident cancers, apparently has affected recent trends in incidence rates for certain cancers, and is important because of increasing prevalence in the U.S. population.
BACKGROUND: Reaching the American Cancer Society challenge goal for the nation to reduce cancer incidence by 25% by 2015 will be influenced in part by the epidemic of obesity. The purpose of this study was to estimate the impact of obesity on the number obesity-attributable incident cancers in the U.S. in 2007 and on trends on cancer incidence rates. METHODS: Using estimated relative risks (RRs) for obesity vs. normal weight/height from published meta-analyses and/or large cohort studies, and the prevalence of obese adults from the latest national surveys, attributable risk percent (ARP) and numbers of obesity-attributed incident cancers in 2007 were estimated. Using the ARPs, the impact of obesity trends on trends in incidence rates for certain obesity-related cancers was estimated for the calendar years (1976-1980 through 2001-2004) for which cancer rates and obesity prevalence rates were available. RESULTS: An estimated 33,966 new cancers (4% of all estimated cancers) in males and 50,535 (7% of all estimated cancers) in females diagnosed in 2007, or 6% of all cancers, may be potentially attributable to obesity. Without the impact of rising obesity rates, incidence rates might have declined (instead of remaining stable) from 1988-1994 to 2001-2004 for uterus, breast and certain other cancers. CONCLUSIONS:Obesity may contribute to about 6% of U.S. incident cancers, apparently has affected recent trends in incidence rates for certain cancers, and is important because of increasing prevalence in the U.S. population.
Authors: Ruth Soriano; Sergio Ponce de León Rosales; Rusia García; Eduardo García-García; Juan Pablo Méndez Journal: J Cancer Educ Date: 2012-06 Impact factor: 2.037
Authors: Ange Wang; FeiFei Qin; Haley Hedlin; Manisha Desai; Rowan Chlebowski; Scarlett Gomez; Charles B Eaton; Karen C Johnson; Lihong Qi; Jean Wactawski-Wende; Catherine Womack; Heather A Wakelee; Marcia L Stefanick Journal: Int J Cancer Date: 2016-11-15 Impact factor: 7.396
Authors: Amy S Joehlin-Price; Julie A Stephens; Jianying Zhang; Floor J Backes; David E Cohn; Adrian A Suarez Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-18 Impact factor: 4.254
Authors: Laura M Welti; Daniel P Beavers; Bette J Caan; Haleh Sangi-Haghpeykar; Mara Z Vitolins; Kristen M Beavers Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-01-09 Impact factor: 4.254
Authors: Jamie J Bernard; You-Rong Lou; Qing-Yun Peng; Tao Li; Priyal R Vakil; Ning Ding; Jeffrey D Laskin; Zigang Dong; Allan H Conney; Yao-Ping Lu Journal: J Carcinog Mutagen Date: 2014-07-31
Authors: Rachel Ballard-Barbash; Sameer M Siddiqi; David A Berrigan; Sharon A Ross; Linda C Nebeling; Emily C Dowling Journal: Am J Prev Med Date: 2013-04 Impact factor: 5.043